Phil Skolnick, Ph.D., D.Sc. (hon.)

Affiliations: 
National Institutes of Health, Bethesda, MD 
Area:
anxiolytic drugs, GABA Receptors, glutamate, benzodiazepines, antidepressants, NMDA receptor
Google:
"Phil Skolnick"
Mean distance: 15.7 (cluster 7)
 
SNBCP

Parents

Sign in to add mentor
John W. Daly post-doc 1972-1977 NIH - NIDDK

Children

Sign in to add trainee
Esther Fride post-doc
Richard Thomas Layer post-doc NIDDK
Piotr Popik post-doc Institute of Pharmacology, Polish Academy of Sciences
Ben Avi Weissman post-doc NIDDK, NIH
Garry Wong post-doc NIH
Todd D. McIntyre post-doc 1986-1990 NIDDK, NIH
Ramon Trullas post-doc 1985-1991 NIDDK
Ian A. Paul post-doc 1989-1993 NIDDK
Li-Ming Zhou post-doc 1992-1994 NIDDK, NIH
Yoshitatsu Sei post-doc 1988-1995 NIDDK
Anthony S. Basile post-doc 1984-1996 NIDDK, NIH
Norman Huang post-doc 1995-1997 NIDDK, NIH
Pierre-Alain Boyer post-doc 1996-1997 NIDDK
Hong Yu research scientist 1997-2001 Eli Lilly & Co
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Krieter PA, Chiang CN, Gyaw S, et al. (2019) Pharmacokinetic Interaction of Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects. Drug Metabolism and Disposition: the Biological Fate of Chemicals
Skolnick P, Kos T, Czekaj J, et al. (2015) Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27: 228-34
Popik P, Holuj M, Nikiforuk A, et al. (2015) 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38
Kim SW, Fowler JS, Skolnick P, et al. (2014) Therapeutic doses of buspirone block D3 receptors in the living primate brain – CORRIGENDUM The International Journal of Neuropsychopharmacology. 17: 1354
Bergman J, Roof RA, Furman CA, et al. (2013) Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 445-58
Warnock KT, Yang AR, Yi HS, et al. (2012) Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology, Biochemistry, and Behavior. 103: 111-8
Newman AH, Blaylock BL, Nader MA, et al. (2012) Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. Biochemical Pharmacology. 84: 882-90
Yang AR, Yi HS, Warnock KT, et al. (2012) Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research. 36: 863-73
Tran P, Skolnick P, Czobor P, et al. (2012) Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research. 46: 64-71
Skolnick P, Popik P, Trullas R. (2010) N-methyl-D-aspartate (NMDA) antagonists for the treatment of depression Milestones in Drug Therapy. 1-20
See more...